Breaking News

Piramal Expands Scotland Mfg. Ops

Invests £2.0 million to expand Grangemouth site to manufacture ADCs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Piramal Healthcare UK Ltd. has invested £2.0 million to expand its manufacturing base at Grangemouth, Scotland, to manufacture Antibody Drug Conjugates for global markets. The new facility will add approximately 20 high-skill jobs and the company expects the investment will yield additional revenue of £3-5 million over a period of five years.   Scotland has become a globally competitive base for sustainable high-value manufacturing. Scotland’s globally competitive Pharma services sector includ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters